CKW Financial Group Purchases 2,800 Shares of Avantor, Inc. (NYSE:AVTR)

CKW Financial Group grew its position in shares of Avantor, Inc. (NYSE:AVTR) by 116.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,200 shares of the company’s stock after acquiring an additional 2,800 shares during the quarter. CKW Financial Group’s holdings in Avantor were worth $110,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Pacer Advisors Inc. lifted its holdings in shares of Avantor by 0.5% during the 4th quarter. Pacer Advisors Inc. now owns 99,825 shares of the company’s stock valued at $2,103,000 after buying an additional 542 shares during the period. Blue Trust Inc. raised its holdings in Avantor by 6.9% in the 4th quarter. Blue Trust Inc. now owns 8,069 shares of the company’s stock worth $170,000 after purchasing an additional 522 shares during the period. Olstein Capital Management L.P. raised its holdings in Avantor by 51.5% in the 4th quarter. Olstein Capital Management L.P. now owns 356,000 shares of the company’s stock worth $7,501,000 after purchasing an additional 121,000 shares during the period. Whalen Wealth Management Inc. bought a new position in Avantor in the 4th quarter worth $566,000. Finally, Nisa Investment Advisors LLC raised its holdings in Avantor by 917.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 20,700 shares of the company’s stock worth $436,000 after purchasing an additional 18,665 shares during the period. 95.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of recent research reports. Raymond James decreased their target price on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a report on Tuesday, January 21st. UBS Group reaffirmed a “neutral” rating and issued a $25.00 target price (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Robert W. Baird decreased their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Wells Fargo & Company cut their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Finally, Barclays cut their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $27.38.

Avantor Trading Up 0.9 %

Shares of Avantor stock opened at $22.07 on Monday. The firm has a market cap of $15.02 billion, a price-to-earnings ratio of 47.97, a PEG ratio of 3.53 and a beta of 1.28. The business has a 50-day moving average price of $21.50 and a 200-day moving average price of $23.43. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.